Peer-reviewedCC BY-NC-NDJournal of thoracic disease
Efficacy and safety of neoadjuvant targeted therapy in surgically treated patients with ALK-rearranged non-small cell lung cancer
- 1Department of Thoracic Surgery , The Affiliated Cancer Hospital of Xiangya School of Medicine/Hunan Cancer Hospital , Central South University , Changsha , ;
Related
- Bowel preparation for colonoscopy in patients with surgically altered anatomy: a narrative review and institutional protocol
- Efficacy and safety of neoadjuvant chemotherapy with toripalimab in locally advanced nasopharyngeal carcinoma: a phase II trial and biological correlate analysis
- Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib
- Neoadjuvant concurrent or sequential anthracycline-containing chemotherapy and HER2-targeted agents for HER2-positive breast cancer: a randomized phase 2 study (METIS).
- Left Ventricular End‐Diastolic Diameter Predicts Clinical Outcomes in Patients Supported With Surgically Implanted Microaxial Flow Pump
BibTeX
@article{liu2026efficacy,
title = {{Efficacy and safety of neoadjuvant targeted therapy in surgically treated patients with ALK-rearranged non-small cell lung cancer}},
author = {Yudong Liu and Li Fang and Zhongjing Jiang and Hao Tang and Yi Gan and Desong Yang},
journal = {Journal of thoracic disease},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13655808},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Efficacy and safety of neoadjuvant targeted therapy in surgically treated patients with ALK-rearranged non-small cell lung cancer
AU - Yudong Liu
AU - Li Fang
AU - Zhongjing Jiang
AU - Hao Tang
AU - Yi Gan
AU - Desong Yang
PY - 2026
DA - 2026/08/14
JO - Journal of thoracic disease
UR - https://europepmc.org/article/PMC/PMC13655808
SN - 2072-1439
SN - 2077-6624
ER -